Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-04 · accession 0001209191-22-017387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-08 | 2022-03-04 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +58.5K | 208.0K | +39% | +$62.0K |
| D | 2022-03-08 | 2022-03-04 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $0.00 | +58.5K | 634.0K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-04 | M | A | 58,500 | $1.06 | 208,018 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-04 | M | A | 58,500 | $0.00 | 634,000 | D | $1.06 · — to 2028-07-22 | 634,000 Class A Common Stock | (F1) Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date. |